IL-21

IL-21 분자 정보

영어 이름Interleukin-21시판 약물 수0
임상 약물 수4표적 별명Za11,IL-21,CVID11,Interleukin-21 Isoform,Interleukin 21
최고 연구 개발 단계Phase 2 Clinical
영어 이름Interleukin-21
표적 별명Za11,IL-21,CVID11,Interleukin-21 Isoform,Interleukin 21
시판 약물 수0
임상 약물 수4
최고 연구 개발 단계Phase 2 Clinical

IL-21 제품 목록

  • 속성

    Protein (11)Kits (1)

  • 제품 라이브러리

    온라인 (12)

  • Human (9)Cynomolgus (2)Mouse (1)

  • 태그

    Fc Tag & Avi Tag (1)Fc Tag (2)Tag Free (6)His Tag (2)- (1)

  • 마커

    Biotin-labeled (1)Unconjugated (10)- (1)

IL-21분자 배경

Interleukin-21 (IL-21) is a secreted protein which belongs to the IL-15 / IL-21 family. Interleukin-21 / IL-21 belongs to a family of cytokines that bind to a composite receptor consisting of a private receptor (IL21R) and the common cytokine receptor gamma chain (gamma(C)). Interleukin-21 / IL-21 impacts a number of cell types, including CD8+ memory T cells, NK cells and subsets of CD4 memory T cells. The IL-21R is widely distributed on lympho-haematopoietic cells. IL-21 is a pleiotropic cytokine produced by CD4+ T cells in response to antigenic stimulation. Its action generally enhances antigen-specific responses of immune cells. IL-21 promotes the anti-tumor activity of CD8+ T-cells and NK cells. IL-21 exerts its effect through binding to a specific type I cytokine receptor, IL-21R, which also contains the γ chain (γc) found in other cytokine receptors including IL-2, IL-4, IL-7, IL-9 and IL-15. The IL-21/IL-21R interaction triggers a cascade of events which includes activation of the tyrosine kinases JAK1 and JAK3, followed by activation of the transcription factors STAT1 and STAT3.

IL-21분자 별명

IL21,Za11,Interleukin-21

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
CVD-1301.V01hV-01; CVD-1301.V01; V 01Phase 2 ClinicalHangzhou Converd Co LtdPancreatic Neoplasms; Sarcoma 180; Solid tumours; Uterine Cervical Neoplasms
상세
IL-21 mab (Lilly)Phase 1 ClinicalEli Lilly And CompanyImmune System Diseases
상세
triple anti-CD19 CAR T-cell therapy/PD-1 checkpoint inhibitor/IL-21 receptor agonist (CD (Suzhou) Biopharma/Chinese People's Liberation Army General Hospital/Chinese academy of sciences)Phase 1 ClinicalChinese Academy Of SciencesHematologic Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma
상세
CD-001CD-001Phase 1 ClinicalCD (Suzhou) Biopharma Co LtdHead and Neck Neoplasms; Hematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasms; Solid tumours
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호